Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3403316
Max Phase: Preclinical
Molecular Formula: C38H56N6O7
Molecular Weight: 708.90
Molecule Type: Small molecule
Associated Items:
ID: ALA3403316
Max Phase: Preclinical
Molecular Formula: C38H56N6O7
Molecular Weight: 708.90
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCN(CC)C(=O)[C@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)COC(=O)[C@@H]1CCCN1C(C)=O)C(C)C
Standard InChI: InChI=1S/C38H56N6O7/c1-8-43(9-2)37(49)31(21-26-16-17-27-13-10-11-14-28(27)20-26)41-35(47)30(19-23(3)4)40-36(48)33(24(5)6)42-34(46)29(39)22-51-38(50)32-15-12-18-44(32)25(7)45/h10-11,13-14,16-17,20,23-24,29-33H,8-9,12,15,18-19,21-22,39H2,1-7H3,(H,40,48)(H,41,47)(H,42,46)/t29-,30-,31-,32-,33-/m0/s1
Standard InChI Key: ZLHTYOGIASNOED-ZTTXAYQISA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 708.90 | Molecular Weight (Monoisotopic): 708.4210 | AlogP: 2.29 | #Rotatable Bonds: 17 |
Polar Surface Area: 180.24 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 13 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 11.99 | CX Basic pKa: 7.22 | CX LogP: 2.08 | CX LogD: 1.86 |
Aromatic Rings: 2 | Heavy Atoms: 51 | QED Weighted: 0.18 | Np Likeness Score: -0.32 |
1. Zhen XL, Yin WH, Tian X, Ma ZJ, Fan SM, Han JR, Liu S.. (2015) Synthesis and biological evaluation of open-chain analogs of cyclic peptides as inhibitors of cellular Shp2 activity., 23 (10): [PMID:25865131] [10.1016/j.bmc.2015.03.035] |
Source(1):